Validation of olfactory deficit as a biomarker of Alzheimer disease

BACKGROUND: We evaluated smell identification as a biomarker for Alzheimer disease (AD) by assessing its utility in differentiating normal aging from an amnestic disorder and determining its predictive value for conversion from amnestic mild cognitive impairment (aMCI) to AD. METHODS: Cross-sectiona...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurol Clin Pract
Asıl Yazarlar: Woodward, Matthew R., Amrutkar, Chaitanya V., Shah, Harshit C., Benedict, Ralph H.B., Rajakrishnan, Sanjanaa, Doody, Rachelle S., Yan, Li, Szigeti, Kinga
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310210/
https://ncbi.nlm.nih.gov/pubmed/28243501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000293
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller